Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000035054Phase 4Recruiting
Phase 4, open-label trial of roxadustat in Uraemic Anaemia (2 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoint: hemoglobin. Started Jul 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000035054.